Janux TherapeuticsJanux Therapeutics
Janux Therapeutics

Janux Therapeutics

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Website
2017Active110
Advertise here

About

Janux Therapeutics is a clinical-stage biopharmaceutical company developing precision-engineered immunotherapies. Their proprietary TRACTr, TRACIr, and ARM platforms are designed to selectively modulate T cells to fight cancer and autoimmune diseases, aiming to transform patients' lives. They are currently evaluating their lead tumor-activated T cell engager (TRACTr) in a clinical trial for prostate cancer.

Technology stack

detected 2026-06-17
Est. monthly stack spend~$880/mo
CDN
Cloudflare
Emailunknown
Stack
jQueryWordPress
Analytics
Google Tag Manager
SEO
Yoast SEO
Cookie consent
OneTrust
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Janux Therapeutics do?

Janux Therapeutics is a clinical-stage biopharmaceutical company developing precision-engineered immunotherapies. Their proprietary TRACTr, TRACIr, and ARM platforms are designed to selectively modulate T cells to fight cancer and autoimmune diseases, aiming to transform patients' lives. They are currently evaluating their lead tumor-activated T cell engager (TRACTr) in a clinical trial for prostate cancer.

How much funding has Janux Therapeutics raised?

Janux Therapeutics has raised a total of $181M in funding. The most recent round on record is Series B.

Where is Janux Therapeutics headquartered?

Janux Therapeutics is headquartered in San Diego, California, USA.

When was Janux Therapeutics founded?

Janux Therapeutics was founded in 2017.

What industry does Janux Therapeutics operate in?

Janux Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare, Immunotherapy, Biotech, HealthTech.

How many employees does Janux Therapeutics have?

Janux Therapeutics has approximately 110 people on record.